BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1848338)

  • 1. Partial depletion of endogenous zinc level by (D-Pen2, D-Pen5)enkephalin in the rat brain.
    Gulya K; Kovács GL; Kása P
    Life Sci; 1991; 48(12):PL57-62. PubMed ID: 1848338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [D-Pen2,D-Pen5]enkephalin, a delta opioid agonist reduces endogenous aluminum content in the rat central nervous system.
    Gulya K; Szikra J; Kása P
    Neuroscience; 1995 May; 66(2):499-506. PubMed ID: 7477890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of endogenous calcium and magnesium levels by delta opioid receptors in the rat brain.
    Gulya K; Kovács GL; Kása P
    Brain Res; 1991 Apr; 547(1):22-7. PubMed ID: 1650284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic administration of [D-Pen2, D-Pen5] enkephalin on the activity of nitric oxide synthase in brain regions and spinal cord of mice.
    Bhargava HN; Cao YJ
    Peptides; 1998; 19(1):113-7. PubMed ID: 9437743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic effect of [D-Pen2,D-Pen5]enkephalin on rat brain opioid receptors.
    Tao PL; Tsai CL; Chang LR; Loh HH
    Eur J Pharmacol; 1991 Aug; 201(2-3):209-14. PubMed ID: 1665782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
    Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
    Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of multiple intracerebroventricular injections of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain delta-opioid receptors.
    Zhao GM; Bhargava HN
    Brain Res; 1997 Jan; 745(1-2):243-7. PubMed ID: 9037415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [D-Pen2,4'-125I-Phe4,D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activity.
    Knapp RJ; Sharma SD; Toth G; Duong MT; Fang L; Bogert CL; Weber SJ; Hunt M; Davis TP; Wamsley JK
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1077-83. PubMed ID: 1653834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
    Heyman JS; Mosberg HI; Porreca F
    NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic and tolerance-inducing effects of the highly selective delta opioid agonist [D-Pen2,D-Pen5]enkephalin in mice.
    Kovács GL; Nyolczas N; Kriván M; Gulya K
    Eur J Pharmacol; 1988 Jun; 150(3):347-53. PubMed ID: 2843384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides.
    Kiritsy-Roy JA; Marson L; Van Loon GR
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1096-103. PubMed ID: 2557411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in mu- and delta-opioid receptors.
    Yoburn BC; Lutfy K; Candido J
    Eur J Pharmacol; 1991 Jan; 193(1):105-8. PubMed ID: 1646725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse.
    Raffa RB; Martinez RP; Porreca F
    Eur J Pharmacol; 1992 Jun; 216(3):453-6. PubMed ID: 1330585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
    Cao YJ; Bian JT; Bhargava HN
    Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogenesis of delta-opioid receptors in rat brain using [3H][D-Pen2,D-Pen5]enkephalin as a binding ligand.
    McDowell J; Kitchen I
    Eur J Pharmacol; 1986 Sep; 128(3):287-9. PubMed ID: 3024998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the binding of [3H][D-Ser2,Thr6]leucine-enkephalin and [3H][D-Pen2,D-Pen5]enkephalin to brain membranes of morphine tolerant-dependent rats.
    Bhargava HN; Gulati A; Rahmani NH
    Eur J Pharmacol; 1991 Sep; 202(3):403-8. PubMed ID: 1660817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.